Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”
Saved in:
Main Authors: | Philippa C. Matthews, Tingyan Wang, Eleanor Barnes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | JHEP Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924002842 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding virologic heterogeneity in chronic hepatitis B treatment
by: Renqi Luo, et al.
Published: (2025-02-01) -
Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
by: Ioannis S. Elefsiniotis, et al.
Published: (2009-01-01) -
Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01) -
Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
by: Young Woon Kim, et al.
Published: (2015-01-01) -
Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
by: Ioannis S Elefsiniotis, et al.
Published: (2004-01-01)